Table 3 MSI status in relation to clinicopathologic features.

Stage

I or II

33

15(93.8%)

7(78.5%)

11(73.3%)

0.28

III

6

1(6.2%)

1(12.5%)

4(26.7%)

Grade

1

20

9(56.3%)

3(37.5%)

8(53.3%)

0.66

2

11

4(25.0%)

4(50.0%)

3(20.0%)

3

8

3(18.7%)

1(12.5%)

4(26.7%)

Depth

Endometrium

15

9(56.3%)

0(0.0%)

6(40.0%)

0.06

<50% of myometrium

18

6(37.5%)

6(75.0%)

6(40.0%)

>50% of myometrium

6

1(6.2%)

2(25.0%)

3(20.0%)

Total

39

16(41.0%)

8(20.5%)

15(38.5%)